Comparative effects of azelnidipine and amlodipine on myocardial function and mortality after ischemia/reperfusion in dogs

Journal of Pharmacological Sciences

Volumn 116, Issue 2, 2011, Pages 181-187

  Kano, Seiichiro ^a   Ichihara, Kazuo ^a   Komatsu, Ken Ichi ^a   Satoh, Kumi ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Azelnidipine; Calcium antagonist; Mortality; Myocardial stunning; Reflex sympathetic hyperactivity

Indexed keywords

AMLODIPINE; AZELNIDIPINE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CHRONOTHERAPY; CHRONOTROPISM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; CORONARY REPERFUSION; DEPRESSOR RESPONSE; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; INOTROPISM; MALE; METABOLIC REGULATION; MORTALITY; NONHUMAN; REPERFUSION INJURY; STUNNED HEART MUSCLE;

EID: 79959337701     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10260FP     Document Type: Article

References (26)

1. Bolli R. Mechanism of myocardial stunning. Circulation. 1990;82:723-738.
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149. (Pubitemid 13238825)
3. duToit EF, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res. 1992;70:960-967.
4. Bush LR, Buja LM, Tilton G, Wathen M, Apprill P, Ashton J, et al. Effect of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation. 1985;72:413-430. (Pubitemid 15019892)
5. Tilton GD, Bush LR, Apprill PG, Buja LM, Willerson JT. Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporally coronary occlusion and long-term reperfusion in conscious dogs. Circulation. 1985;71:165-175. (Pubitemid 15164778)
6. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
7. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
8. Yui Y, Sumiyoshi T, Kodama K, Nonogi H, Kanmatsuse K, Origasa H, et al. Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan multicenter investigation for cardiovascular diseases-B (JMIC-B) randomized trial. Hypertens Res. 2004;27:181-191. (Pubitemid 38489080)
9. Kuramoto K, Ichikawa S, Hirai A, Kanda S, Nakachi T, Ogihara T. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res. 2003;26:201-208. (Pubitemid 36443033)
10. Wellington K, Scott LJ. Azelnidipine. Drugs. 2003;63:2613-2621.
11. Satoh K, Yamamoto A, Hoshi K, Ichihara K. Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs. Jpn J Pharmacol. 1998;76:369-376. (Pubitemid 28227079)
12. Kano S, Nakai T, Kohri H, Ichihara K. Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs. Coronary Artery Disease. 1995;6:811-818. (Pubitemid 26037329)
13. Bergmeyer HU. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 1984-1985.
14. Nakaya H, Schwartz A, Millard RW. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Circ Res. 1983;52:302-311. (Pubitemid 13158745)
15. Stone PH, Gibson RS, Glasser SP, DeWood MA, Parker JD, Kawanishi DT, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation. 1990;82:1962-1972.
16. Steffen HM. Amlodipine-a third generation dihydropyridine calcium antagonist. J Clin Basic Cardiol. 1999;2:45-52.
17. Koike H, Kimura T, Kawasaki T, Sada T, Ikeda T, Sanbuissho A, et al. Azelnidipine, a long-acting calcium channel blocker with slow onset and high vascular affinity. Annu Rep Sankyo Res Lab. 2002;54:1-64.
18. Li M, Hansen B, Huang L, Keyser BM, Taylor JT. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Cardiovasc Drug Rev. 2005;23:173-196. (Pubitemid 41278975)
19. Cohen CJ, Spires S, Skiver DV. Block of T-type Ca channels in guinea pig artrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992;100:703-728.
20. Perez-Reyes E, Van Deusen AL, Vitko I. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: Block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther. 2009;328:621-627.
21. Ichihara K, Satoh K. [Microcirculation in the myocardium.] Floia Pharmacol Jpn (Nihon Yakurigaku Zasshi). 1999;113:227-234. (text in Japanese with English abstract)
22. Bonden WE, Korr KS, Bough EW. Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. JAMA. 1985;253:1131-1135 (Pubitemid 15103821)
23. Nakai T, Kano S, Satoh K, Hoshi K, Ichihara K. Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. J Cardiovasc Pharmacol. 1996;28:264-270. (Pubitemid 26322833)
24. Buja LM, Hagler HK, Willerson JT. Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. Cell Calcium. 1988;9:205-217. (Pubitemid 19026982)
25. Gross GJ, Farber NE, Pieper GM. Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs. Cardiovasc Drugs Ther. 1989;3:535-543. (Pubitemid 19262255)
26. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest. 2006;116:1063-1070.